跳至主要内容
临床试验/NCT02537899
NCT02537899已完成4 期

A Case Series of Patients With Spinal Cord Injury Treated With Standard Therapies and NeuroAiD

Moleac Pte Ltd.1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2015年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
30
试验地点
1
主要终点
Spinal cord injury severity based on American Spinal Injury Association Impairment Scale

研究概览

简要总结

SATURN investigates the promising role of NeuroAiD in patients with spinal cord injury and will provide important information on the feasibility of conducting larger controlled trials.

详细描述

SATURN is a prospective cohort study of patients with moderately-severe to severe spinal cord injury, defined as American Spinal Injury Association Impairment Scale A and B, who are treated with open-label NeuroAiD for 6 months in addition to standard care and followed for 24 months. Anonymized data will be prospectively collected at baseline and months 1, 3, 6, 12, 18, and 24 using a secured online system and will include information on demographics, main diagnostics, neurological and functional state, treatment compliance, concomitant therapies, and side effects, if any.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female
  • Age 18 to 65 years
  • Diagnosed with spinal cord injury between 3 days and 4 weeks
  • American Spinal Injury Association Impairment Scale A or B
  • Informed consent for inclusion into the database is obtained

排除标准

  • Non survivable injury
  • Multiple significant trauma (i.e. significant intracranial and extracranial injuries including limb fractures) that would limit observation of recovery from spinal cord injury
  • Other conditions that would limit clinical assessment of outcomes (e.g. dementia, demyelinating disease, autoimmune disease, etc)
  • Refusal of treatment or contraindication to NeuroAiD

研究组 & 干预措施

Treatment

Other

NeuroAiD

干预措施: NeuroAiD (Drug)

结局指标

主要结局

Spinal cord injury severity based on American Spinal Injury Association Impairment Scale

时间窗: 6 months

Number of patients experiencing adverse events

时间窗: 6 months

Adverse events as individual events and according to organ system, severity, and relatedness

Motor recovery based on American Spinal Injury Association Impairment Scale motor score

时间窗: 6 months

次要结局

  • Spinal cord injury severity based on American Spinal Injury Association Impairment Scale(1, 3, 12, 18, 24 months)
  • Motor recovery based on American Spinal Injury Association Impairment Scale motor score(1, 3, 12, 18, 24 months)
  • Sensory recovery based on American Spinal Injury Association Impairment Scale sensory score(1, 3, 6, 12, 18, 24 months)
  • Functional state based on Spinal Cord Independence Measure(1, 3, 6, 12, 18, 24 months)
  • Quality of life based on Short Form-8 Health Survey(1, 3, 6, 12, 18, 24 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验